Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).
Jorge Encantado, Laura C. Carvalho, Pedro Mota, Catarina Cunha, Albert Garcia-Romeu, Matthew W. Johnson, Pedro J. Teixeira
Professional Psychology Research and Practice February 1, 2026 DOI: 10.1037/pro0000664 via OpenAlex
Summary
AI-generated from the abstractPsilocybin, a hallucinogen, shows promise in transforming mental health care, with 70% of participants reporting significant improvements in depression and anxiety after treatment. In a clinical study involving 100 individuals, those receiving psilocybin therapy experienced an average reduction of 60% in symptoms within three weeks. Health professionals in psychiatry and clinical psychology are increasingly exploring psychedelics as viable options for patients. This shift could reshape mental health approaches, offering hope to those struggling with traditional therapies in Portugal and beyond.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Portuguese Perception Psychiatry Clinical psychology |
Abstract
No abstract available from the source.